Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009

Japanese Journal of Infectious Diseases

Volumn 65, Issue 6, 2012, Pages 510-515

  Zhang, Xiao Bing ^a   Yu, Shuang Jiang ^a   Yu, Jun Xiao ^a   Gong, Ya Li ^a   Feng, Wei ^a   Sun, Feng Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CHILD; CHINA; CONCURRENT INFECTION; DEMOGRAPHY; ENDOTRACHEAL INTUBATION; FEMALE; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; HYPOPROTEINEMIA; INFANT; KIDNEY FAILURE; MALE; MEDICAL RECORD; MORTALITY; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; CHINA; CROSS INFECTION; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84869787782     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.65.510     Document Type: Article

References (37)

1. Klevens, R.M., Edwards, J.R., Richards, C.L., et al. (2007): Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep., 122, 160-166.
2. Wisplinghoff, H., Bischoff, T., Tallent, S.M., et al. (2004): Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis., 39, 309-317.
3. Edmond, M.B., Wallace, S.E., McClish, D.K., et al. (1999): Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis., 29, 239-244.
4. Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention (1998): National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am. J. Infect. Control, 26, 522-533.
5. Pfaller, M. and Wenzel, R. (1992): Impact of the changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis., 11, 287-291.
6. Chang, A., Neofytos, D. and Horn, D. (2008): Candidemia in the 21st century. Future Microbiol., 3, 463-472.
7. Tortorano, A.M., Biraghi, E., Astolfi, A., et al. (2002): European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J. Hosp. Infect., 51, 297-304.
8. Fridkin, S.K. (2005): The changing face of fungal infections in health care settings. Clin. Infect. Dis., 41, 1455-1460.
9. Blumberg, H.M., Jarvis, W.R., Soucie, J.M., et al. (2001): Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin. Infect. Dis., 33, 177-186.
10. Kuhn, D.M., Mikherjee, P.K., Clark, T.A., et al. (2004): Candida parapsilosis characterization in an outbreak setting. Emerg. Infect. Dis., 10, 1074-1081.
11. Pfaller, M.A. and Diekema, D.J. (2007): Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev., 20, 133-163.
12. Pappas, P.G., Rex, J.H., Sobel, J.D., et al. (2004): Guidelines for treatment of candidiasis. Clin. Infect. Dis., 38, 161-189.
13. Zaoutis, T.E., Argon, J., Chu, J., et al. (2005): The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis., 41, 1232-1239.
14. Falagas, M.E., Apostolou, K.E. and Pappas, V.D. (2006): Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur. J. Clin. Microbiol. Infect. Dis., 25, 419-425.
15. National Committee for Clinical Laboratory Standards (2004): Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline M44-A. Wayne, Pa.
16. Rosco Diagnostica (2005): Users Guide to Neo-Sensitabs. Rosco, Denmark.
17. Tsai, C.C., Wang, C.C., Kuo, H.Y., et al. (2008): Adult candidemia at a medical center in northern Taiwan: a retrospective study. J. Microbiol. Immunol. Infect., 41, 414-421.
18. Fan, S.R., Liu, X.P. and Li, J.W. (2008): Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. J. Obstet. Gynaecol. Res., 34, 561-566.
19. Presterl, E., Daxb, C.K., F., Graninger, W., et al. (2007): Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin. Microbiol. Infect., 13, 1072-1076.
20. Metwally, L., Walker, M.J., Coyle, P.V., et al. (2007): Trends in candidemia and antifungal susceptibility in a university hospital in northern Ireland 2001-2006. J. Infect., 55, 174-178.
21. Xess, I., Jain, N., Hasan, F., et al. (2007): Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection, 35, 256-259.
22. Horn, D.L., Neofytos, D., Anaissie, E.J., et al. (2009): Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis., 48, 1695-1703.
23. Thomas, J.G. and Madigan, M. (1997): A retrospective study to evaluate a computer based model of amplifying, 1) early antifungal intervention and 2) microbial detection of patients at risk for fungemia [abstract]. 7th Annual Focus on Fungal Interaction, San Antonio, Texas, March 13-15.
24. Ishikawa, T., Takata, T., Akamatsu, S., et al. (2010): Analysis of Candida glabrata strains with reduced sensitivity to micafungin in vitro isolated from a patient with persistent candidemia. Jpn. J. Infect. Dis., 63, 332-337.
25. Abi-Said, D., Anaissie, E., Uzun, O., et al. (1997): The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis., 24, 1122-1128.
26. Sendid, B., Cotteau, A., Francois, N., et al. (2006): Candidaemia and antifungal therapy in a French university hospital: rough trends over a decade and possible links. BMC Infect. Dis., 6, 80-88.
27. Trick, W., Fridkin, S., Edwards, J., et al. (2002): Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis., 35, 627-630.
28. Rueping, M.J., Vehreschild, J.J. and Cornely, O.A. (2009): Invasive candidiasis and candidemia: from current opinions to future perspectives. Expert Opin. Investig. Drugs, 18, 735-748.
29. Lewis, R.E. (2009): Overview of the changing epidemiology of candidemia. Curr. Med. Res. Opin., 25, 1732-1740.
30. Barchiesi, F., Caggiano, G., Falconi Di Francesco, L., et al. (2004): Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit. Diagn. Microbiol. Infect. Dis., 49, 269-271.
31. Dizbay, M., Kalkanci, A., Sezer, B., et al. (2008): Molecular investigation of a fungemia outbreak due to Candida parapsilosis in an intensive care unit. Braz. J. Infect. Dis., 12, 395-399.
32. Fridkin, S., Kaufman, D., Edwards, J., et al. (2006): Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics, 117, 1680-1687.
33. Yin, Q., Zhang, Y. and Fang, Q. (2008): Study on the morbidity and pathogens of patients with candidemia at the intensive care unit. Chin. J. Epidemiol., 29, 464-466 (in Chinese).
34. Blot, S., Vandijck, D. and Vandewoude, K. (2008): Risk factors for Candida non-albicans candidemia. Diagn. Microbiol. Infect. Dis., 61, 362-363.
35. Chow, J.K., Golan, Y., Ruthazer, R., et al. (2008): Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit. Care Med., 36, 1993-1998.
36. Medrano, D.J., Brilhante, R.S., Cordeiro Rde, A., et al. (2006): Candidemia in a Brazilian hospital: the importance of Candida parapsilosis. Rev. Inst. Med. Trop. Sao Paulo, 48, 17-20.
37. Diekema, D.J., Beekmann, S.E., Chapin, K.C., et al. (2003): Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J. Clin. Microbiol., 41, 3655-3660.